ChitogenX Financial Statements From 2010 to 2024
| CHNXF Stock | USD 0.01 0.0001 2.00% |
Check ChitogenX financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ChitogenX's main balance sheet or income statement drivers, such as , as well as many indicators such as . ChitogenX financial statements analysis is a perfect complement when working with ChitogenX Valuation or Volatility modules.
ChitogenX |
ChitogenX OTC Stock Shares Owned By Insiders Analysis
ChitogenX's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current ChitogenX Shares Owned By Insiders | 17.44 % |
Most of ChitogenX's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChitogenX is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 17.44% of ChitogenX are shares owned by insiders. This is 14.89% higher than that of the Healthcare sector and 22.99% higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is 72.84% lower than that of the firm.
ChitogenX Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ChitogenX's current stock value. Our valuation model uses many indicators to compare ChitogenX value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChitogenX competition to find correlations between indicators driving ChitogenX's intrinsic value. More Info.ChitogenX is number one stock in return on asset category among its peers. It also is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ChitogenX's earnings, one of the primary drivers of an investment's value.About ChitogenX Financial Statements
ChitogenX stakeholders use historical fundamental indicators, such as ChitogenX's revenue or net income, to determine how well the company is positioned to perform in the future. Although ChitogenX investors may analyze each financial statement separately, they are all interrelated. For example, changes in ChitogenX's assets and liabilities are reflected in the revenues and expenses on ChitogenX's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ChitogenX. Please read more on our technical analysis and fundamental analysis pages.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada. Chitogenx is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in ChitogenX OTC Stock
ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.